{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:49:42Z","timestamp":1754153382877,"version":"3.41.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/ijgc-2023-004279","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T10:13:29Z","timestamp":1680257609000},"page":"707-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: could it be a new marker?"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-9652","authenticated-orcid":false,"given":"Mine","family":"Daggez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Dolanbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hulya","family":"Akgun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-8305","authenticated-orcid":false,"given":"Varol","family":"G\u00fclseren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem Ak\u00e7a","family":"Keklikcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Ozcelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Serdar","family":"Serin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004279_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2023-004279_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.2004.021071","article-title":"EIN and WHO94","volume":"58","author":"Baak","year":"2005","journal-title":"J Clin Pathol"},{"first-page":"125","year":"2014","author":"Zaino","key":"10.1136\/ijgc-2023-004279_bb0020"},{"key":"10.1136\/ijgc-2023-004279_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of untreated hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-004279_bb0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7827-10-24","article-title":"HCG, the wonder of today\u2019s science","volume":"10","author":"Cole","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1136\/ijgc-2023-004279_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2010.07.014","article-title":"Does HCG or hCG\u03b2 play a role in cancer cell biology?","volume":"329","author":"Iles","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1136\/ijgc-2023-004279_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mc.22499","article-title":"Gonadotropin and tumorigenesis: direct and indirect effects on inflammatory and immunosuppressive mediators and invasion","volume":"56","author":"Khare","year":"2017","journal-title":"Mol Carcinog"},{"key":"10.1136\/ijgc-2023-004279_bb0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1095\/biolreprod.108.069575","article-title":"Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle","volume":"80","author":"Zimmermann","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1136\/ijgc-2023-004279_bb0050","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2008.08.018","article-title":"HLH\/HCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer","volume":"111","author":"Noci","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004279_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5301\/ijbm.5000290","article-title":"The importance of hCG in human endometrial adenocarcinoma and breast cancer","volume":"33","author":"K\u00f6lbl","year":"2018","journal-title":"Int J Biol Markers"},{"key":"10.1136\/ijgc-2023-004279_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/IGC.0b013e3181bbe933","article-title":"Expression of hCG and GNRHs and their receptors in endometrial carcinoma and hyperplasia","volume":"20","author":"Jankowska","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004279_bb0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.25689","article-title":"LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis","volume":"129","author":"Yin","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2023-004279_bb0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/gyno.2001.6434","article-title":"Endometrial cancer in women 40 years old or younger","volume":"83","author":"Duska","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004279_bb0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-004279_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004279_bb0085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/IGC.0000000000000669","article-title":"Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: a Korean Gynecologic-Oncology Group study","volume":"26","author":"Kim","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004279_bb0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5468\/ogs.19169","article-title":"Fertility-sparing treatment in early endometrial cancer: current state and future strategies","volume":"63","author":"Obermair","year":"2020","journal-title":"Obstet Gynecol Sci"},{"key":"10.1136\/ijgc-2023-004279_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2019.01.014","article-title":"Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer","volume":"153","author":"Yang","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004279_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijgo.12882","article-title":"A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma","volume":"146","author":"Guillon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004279_bb0105","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/aogs.13587","article-title":"Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review","volume":"98","author":"Travaglino","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1136\/ijgc-2023-004279_bb0110","first-page":"417","article-title":"Adenocarcinoma of the endometrium in women 40 years of age or younger","volume":"64","author":"Gallup","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004279_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.1997.4656","article-title":"Increased expression of LH\/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women","volume":"65","author":"Konishi","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004279_bb0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00000421-200212000-00004","article-title":"Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"25","author":"Asbury","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004279_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1054\/bjoc.2001.1900","article-title":"Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide","volume":"85","author":"Noci","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2023-004279_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/15384101.2018.1558869","article-title":"\u0392-HCG promotes epithelial ovarian cancer metastasis through ERK\/MMP2 signaling pathway","volume":"18","author":"Wu","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1136\/ijgc-2023-004279_bb0135","first-page":"22","article-title":"HCG variants, the growth factors which drive human malignancies","volume":"2","author":"Cole","year":"2012","journal-title":"Am J Cancer Res"},{"key":"10.1136\/ijgc-2023-004279_bb0140","doi-asserted-by":"crossref","first-page":"873","DOI":"10.15537\/smj.2018.9.22710","article-title":"The re-awakening of hCG expression. Its role in the diagnosis of cervical squamous cell carcinoma","volume":"39","author":"Bozdag","year":"2018","journal-title":"Saudi Med J"},{"key":"10.1136\/ijgc-2023-004279_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000486770","article-title":"B subunit of human chorionic gonadotropin promotes tumor invasion and predicts poor prognosis of early-stage colorectal cancer","volume":"45","author":"Li","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1136\/ijgc-2023-004279_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071587","article-title":"Human chorionic gonadotropin and breast cancer","volume":"18","author":"Sch\u00fcler-Toprak","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1136\/ijgc-2023-004279_bb0155","article-title":"The expression of beta human chorionic gonadotrophin (\u03b2-HCG) in human urothelial carcinoma","volume":"7","author":"Venyo","year":"2010","journal-title":"Pan Afr Med J"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24024174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24024174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:53Z","timestamp":1753234133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24024174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1048891X24024174"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004279","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: could it be a new marker?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}